TIM-3 is expressed on the surface of different kinds of T-cells (CD4+ cells, CD8+ cells [28], T-reg cells [29], and Th17 cells) [30], but also on the surface of APCs, and it exerts its activity upon binding the galectin-9 expressed on tumor cells. This evidence concerns the gene CD4 and neoplasm.